logo

For the Inventor, By the Inventor

Ludwigshafen, Germany

Jayne Froggett

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jayne Froggett. Retrieved from https://idiyas.com/inventor/jayne-froggett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Speyer, DE (2014)
  • Ludwigshafen, DE (2015 - 2017)

Company Filing History:

goldMedal3 out of 167 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
silverMedal1 out of 826 
 
Abbvie Inc.
 patents
where one patent can have more than one assignee

Years Active: 2014-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 9617226 - Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases (2017-04-11),
2. 9200005 - Inhibitor compounds of phosphodiesterase type 10A (2015-12-01),
3. 8664214 - Small molecule potentiators of metabotropic glutamate receptors I (2014-03-04),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees and patents, I can provide you with a detailed article about inventor Jayne Froggett based on the given data.

Title: Unveiling the Inventive Mind of Jayne Froggett: Pioneering Innovation in Ludwigshafen

Introduction

In the vibrant city of Ludwigshafen, Germany, inventor Jayne Froggett has made significant strides in the field of pharmaceuticals with a remarkable portfolio of patented inventions.

Latest Patents

Jayne Froggett's recent patents showcase his ingenuity in developing compounds for treating vasopressin-related diseases and inhibitors of phosphodiesterase type 10A. These compounds hold immense promise for revolutionizing the treatment of neurological and psychiatric disorders.

Career Highlights

With a total of three patents to his name, Jayne Froggett has demonstrated a keen understanding of pharmacological advancements. His contributions in the formulation of novel compounds highlight his dedication to pioneering medical innovation.

Collaborations

Throughout his career, Jayne Froggett has collaborated with esteemed professionals in the field, including coworkers Katja Jantos and Hervé Geneste. Together, they have synergized their expertise to push the boundaries of pharmaceutical research.

Conclusion

In conclusion, Jayne Froggett's inventive spirit shines through his groundbreaking patents in the realm of pharmaceuticals. His collaborations and career highlights testify to his commitment to driving innovation and making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…